Felix Gonzalez is CEO and co-founder of FounderNest.
Using patent intelligence data from the FounderNest platform, alongside funding, partnership, and deployment signals across the market, Felix Gonzalez highlights where AI and digital technologies are gaining traction in pharmaceutical development and manufacturing, and what it means for competition this year.
Using patent intelligence data from the FounderNest platform, Gonzalez highlights where small-molecule synthesis, formulation, and manufacturing innovation is accelerating, and what it means for pharma competition this year.
Felix Gonzalez, FounderNest, offers a data-driven view of where pharma consolidation is occurring, where capital is being deployed, and how regional M&A strategies differ.
